Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Other Accumulated Expenses: 2023-2025

Historic Other Accumulated Expenses for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $266.4 million.

  • Ardent Health's Other Accumulated Expenses rose 613.96% to $266.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $266.4 million, marking a year-over-year increase of 613.96%. This contributed to the annual value of $239.8 million for FY2024, which is 280.92% up from last year.
  • Latest data reveals that Ardent Health reported Other Accumulated Expenses of $266.4 million as of Q3 2025, which was up 613.96% from $237.9 million recorded in Q2 2025.
  • Over the past 5 years, Ardent Health's Other Accumulated Expenses peaked at $278.4 million during Q2 2024, and registered a low of $226.3 million during Q1 2025.
  • Its 3-year average for Other Accumulated Expenses is $247.6 million, with a median of $239.8 million in 2024.
  • The largest annual percentage gain for Ardent Health's Other Accumulated Expenses in the last 5 years was 613.96% (2025), contrasted with its biggest fall of 1452.99% (2025).
  • Quarter analysis of 3 years shows Ardent Health's Other Accumulated Expenses stood at $233.3 million in 2023, then grew by 2.81% to $239.8 million in 2024, then increased by 11.06% to $266.4 million in 2025.
  • Its Other Accumulated Expenses stands at $266.4 million for Q3 2025, versus $237.9 million for Q2 2025 and $226.3 million for Q1 2025.